Clinical Trials Logo

Clinical Trial Summary

Maternal deaths due to uterine atony bleeding are the leading causes of maternal death in our country and all over the world. In this respect, our clinic is among the clinics with the highest number of experience in our country and aims to reduce maternal deaths and mothers who will need intensive care due to bleeding with a hemorrhage stopping technique that will have a serious contribution to both our country and the world literature. Our primary goal, thanks to the bleeding-stopping technique, to reduce their deaths. Our secondary aim is, thanks to the bleeding-stopping technique we offer, To prevent and reduce the complications seen in mothers during the operative period.


Clinical Trial Description

Our research was carried out to our obstetrics clinic between 01 Agustus 2015 - 01 December 2020. Patients transplanted due to postpartum bleeding and patients requiring surgery due to abnormal postpartum bleeding in our clinic will be included. Patients with a previously known bleeding disorder will not be included in the study. In our study, the parameters of the patients who had bleeding due to postpartum uterine atony and who needed uterine surgery previously underwent triple Hayman compression suture to stop bleeding will be included in the study. Patients with a triple Hayman suture covering the upper 2/3 of the uterus to stop uterine bleeding will be evaluated in the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04690153
Study type Observational
Source Kanuni Sultan Suleyman Training and Research Hospital
Contact
Status Completed
Phase
Start date August 15, 2015
Completion date December 15, 2020

See also
  Status Clinical Trial Phase
Enrolling by invitation NCT02910115 - Cooling the Uterus in C-section After Dysfunctional Labor N/A
Withdrawn NCT02410655 - An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery Phase 4
Completed NCT00790062 - Oxytocin Regimen to Prevent Atony and Postpartum Hemorrhage During Vaginal Delivery: 3-arm RCT Phase 4
Recruiting NCT01579201 - ED90 Determination of Carbetocin for the Prevention of Uterine Atony in Women Undergoing an Elective Cesarean Delivery Phase 4
Completed NCT03867383 - Calcium Chloride for Prevention of Uterine Atony During Cesarean Phase 1/Phase 2
Active, not recruiting NCT03584854 - Second-Line Uterotonics in Postpartum Hemorrhage: A Randomized Clinical Trial Phase 4
Completed NCT02780245 - Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section Phase 4
Completed NCT00785395 - Up-Down Oxytocin Infusion Phase 4
Withdrawn NCT03303235 - Intravenous Versus Intramuscular Administration of Methylergonovine for Uterine Contraction in Cesarean Sections Early Phase 1
Completed NCT02229513 - Uterine Cooling During Cesarean Delivery to Reduce Blood Loss and Incidence of Postpartum Hemorrhage N/A
Not yet recruiting NCT06192836 - Placental Removal Method And Uterine Massage On Preventing Postpartum Hemorrhage
Recruiting NCT03413917 - Exploration and Determination of Genomic Markers Predictive of Uterine Atony
Withdrawn NCT01252342 - Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? Phase 4
Completed NCT05027048 - Calcium Chloride for Prevention of Blood Loss During Intrapartum Cesarean Delivery Phase 3
Completed NCT01630187 - Comparison of Two Doses of Carbetocin for Prevention of Uterine Atony, During Elective Cesarean Section Phase 4
Completed NCT01549223 - Oxytocin And Uterotonic Agent Use For Cesarean Delivery Phase 4